Federal Register / Vol. 86, No. 113 / Tuesday, June 15, 2021 / Notices 31715 

TABLE II—NOCS APPROVED * FROM 05/01/2021 TO 05/31/2021—Continued 

Case No. Received date Commencement 

date 

If Amendment, 

type of 

amendment 

Chemical substance 

P–17–0360A .. 05/05/2021 02/01/2021 Multiple 

CASRN submitted on 

single NOC.

(S) 2-propanol, 1-amino-,compd. with.alpha.-sulfo-.omega.- 

(octyloxy)poly(oxy-1,2-ethanediyl)(1:1). 

P–18–0041 ..... 05/07/2021 03/09/2021 N .................... (S) 2,5-furandione, polymer with 2-ethyl-2-(hydroxymethyl)-1,3- 

propanediol, 3a,4,5,6,7,7a-hexahydro-4,7-methano-1h-inden-5(or 6)-yl 

ester, ester with 2,3-dihydroxypropyl neodecanoate. 

P–18–0334 ..... 05/20/2021 04/22/2021 N .................... (S) Propanedioic acid, 1,3-dihexyl ester. 

P–18–0335 ..... 05/20/2021 04/22/2021 N .................... (S) Propanedioic acid, 1,3-dicyclohexyl ester. 

P–18–0336 ..... 05/25/2021 05/11/2021 N .................... (S) Propanedioic acid, 2,2-bis(hydroxymethyl)-, 1,3-dihexyl ester. 

P–18–0351 ..... 05/10/2021 05/04/2021 N .................... (G) Acrylic acid, tricyclo alkyl ester. 

P–20–0036 ..... 05/18/2021 05/14/2021 N .................... (S) Carbonic acid, di(lithium-6li) salt. 

P–20–0159 ..... 04/30/2021 04/06/2021 N .................... (G) Phenoxathiinium, 10-phenyl, 5-alkyl-2-alkyl-4-(2,4,6-substituted tricarbomonocycle, hetero-acid)benzenesulfonate (1:1). 

P–21–0018 ..... 04/30/2021 04/06/2021 N .................... (G) Sulfonium, triphenyl-, heterocyclic compound-carboxylate (1:1). 

* The term ‘Approved’ indicates that a submission has passed a quick initial screen ensuring all required information and documents have been 

provided with the submission. 

In Table III of this unit, EPA provides 

the following information (to the extent 

such information is not subject to a CBI 

claim) on the test information that has 

been received during this time period: 

The EPA case number assigned to the 

test information; the date the test 

information was received by EPA, the 

type of test information submitted, and 

chemical substance identity. 

TABLE III—TEST INFORMATION RECEIVED FROM 05/01/2021 TO 05/31/2021 

Case No. Received date Type of test information Chemical substance 

P–16–0289 ...... 05/26/2021 Particle Size Analysis .................................................. (G) Semi-aromatic polyamide. 

P–16–0462 ...... 05/10/2021 Quarter 1 Metals Report .............................................. (G) Silane-treated aluminosilicate. 

P–16–0543 ...... 05/12/2021 Exposure Monitoring Report ........................................ (G) Halogenophosphoric acid metal salt. 

P–18–0160 ...... 05/20/2021 14-Day Range-Finding Study and Combined Repeated Dose Toxicity Study with Reproductive-Developmental Toxicity Test.(G) Heteropolycyclic, halo substituted alkyl 

substituted- diaromatic amino substituted 

carbomonocycle, halo substituted alkyl substituted 

heteropolycyclic, tetraaromatic metalloid salt (1:1). 

P–20–0044 ...... 05/26/2021 Freshwater Algal Growth Inhibition Test (OECD Test 

Guideline 201).

(S) 1-propanamine, 3-methoxy-n,n-dimethyl. 

P–20–0073 ...... 05/11/2021 Ready Biodegradability Manometric Respirometry 

Tests (OECD Test Guideline 301F), Assessment of 

Aerobic Degradability in Seawater, Assessment of 

the 10 day LC50 Toxicity to the Marine Crustacean 

Corophium Volutator (OSPARCOM Part A Method), Assessment of the Toxicity to the Marine fish 

Cyprinodon Variegatus (OSPAR Limit Test), Assessment of the 72 Hour EC(r)50 toxicity to the 

Marine Unicellular Algae Skeletonema sp., and 

Manufacture Process Description.

(G) 2,5-furandione, reaction products with alkylamine, 

1-octanol and polyethylene glycol alkoxy-ether, 

acetates (salts). 

If you are interested in information 

that is not included in these tables, you 

may contact EPA’s technical 

information contact or general 

information contact as described under 

FOR FURTHER INFORMATION CONTACT to 

access additional non-CBI information 

that may be available. 

Authority: 15 U.S.C. 2601 et seq. 

Dated: June 9, 2021. 

Pamela Myrick, 

Director, Project Management and Operations 

Division, Office of Pollution Prevention and 

Toxics. 

[FR Doc. 2021–12504 Filed 6–14–21; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA R09–2021–08; FRL–10024–41–Region 

9] 

Notice of Proposed CERCLA Section 

122(h)(1) Settlement for Cost Recovery 

of Past Response Costs at the Santa 

Clara Waste Water Treatment Plant 

Emergency Removal Site, Santa Paula, 

California 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice of proposed settlement; 

request for public comment. 

SUMMARY: In accordance with the 

Comprehensive Environmental 

Response, Compensation and Liability 

Act of 1980, as amended (‘‘CERCLA’’), 

notice is hereby given that the 

Environmental Protection Agency 

(‘‘EPA’’), has entered into a proposed 

settlement, embodied in a CERCLA 

Section 122(h)(1) Settlement for Cost 

Recovery (‘‘Settlement Agreement’’), 

with Santa Clara Waste Water Company 

(‘‘SCWW’’). Under the Settlement 

Agreement, SCWW agrees to pay some 

of EPA’s past response costs at the Santa 

Clara Waste Water Treatment Plant 

Emergency Removal Site, Santa Paula, 


khammond on DSKJM1Z7X2PROD with NOTICES
31716 Federal Register / Vol. 86, No. 113 / Tuesday, June 15, 2021 / Notices 

California (‘‘Site’’) in Santa Paula, 

California. 

DATES: Comments must be received on 

or before July 15, 2021. 

ADDRESSES: The proposed settlement 

agreement is available for public 

inspection at https://cumulis.epa.gov/ 

supercpad/cursites/ 

csitinfo.cfm?id=0900238. Comments on 

the Settlement Agreement should be 

submitted in writing to Rebekah 

Reynolds at reynolds.rebekah@epa.gov. 

Comments should reference the Santa 

Clara Waste Water Treatment Plant 

Emergency Removal Site and the EPA 

Docket Number for the Settlement 

Agreement, EPA R9–2021–08. If for any 

reason you are not able to submit a 

comment by email, please contact Ms. 

Reynolds at (415) 972–3916 to make 

alternative arrangements for submitting 

your comment. EPA will post its 

response to any comments at https://

response.epa.gov/site/site_

profile.aspx?site_id=9634, EPA’s 

website for the Site. 

FOR FURTHER INFORMATION CONTACT: 

Rebekah Reynolds, Assistant Regional 

Counsel (ORC–3), Office of Regional 

Counsel, U.S. EPA Region IX, 75 

Hawthorne Street, San Francisco, CA 

94105; Email: reynolds.rebekah@

epa.gov; Phone: (415) 972–3916. 

SUPPLEMENTARY INFORMATION: Notice of 

this proposed administrative settlement 

is made in accordance with Section 

122(i) of CERCLA. The Settlement 

Agreement concerns past response costs 

incurred by EPA to perform oversight at 

the Site. Under the Settlement 

Agreement, SCWW agrees to pay EPA 

$111,000 for past response costs. The 

Settlement Agreement includes a 

covenant not to sue SCWW for past 

response costs pursuant to Section 

107(a) of CERCLA. EPA will consider all 

comments received on the Settlement 

Agreement in accordance with the 

DATES and ADDRESSES sections of this 

Notice and may modify or withdraw its 

consent to the Settlement Agreement if 

comments received disclose facts or 

considerations that indicate that the 

settlement is inappropriate, improper, 

or inadequate. 

Dated: June 7, 2021. 

Enrique Manzanilla, 

Director, Superfund Division, EPA Region 9. 

[FR Doc. 2021–12459 Filed 6–14–21; 8:45 am] 

BILLING CODE 6560–50–P 

FEDERAL DEPOSIT INSURANCE 

CORPORATION 

Sunshine Act Meeting 

TIME AND DATE: 10:00 a.m. on Tuesday, 

June 15, 2021. 

PLACE: The meeting is open to the 

public. Out of an abundance of caution 

related to current and potential 

coronavirus developments, the public’s 

means to observe this Board meeting 

will be via a Webcast live on the 

internet and subsequently made 

available on-demand approximately one 

week after the event. Visit http://

fdic.windrosemedia.com to view the 

live event. Visit http://

fdic.windrosemedia.com/index.php?

category=FDIC+Board+Meetings after 

the meeting. If you need any technical 

assistance, please visit our Video Help 

page at: https://www.fdic.gov/ 

video.html. 

Observers requiring auxiliary aids 

(e.g., sign language interpretation) for 

this meeting should call 703–562–2404 

(Voice) or 703–649–4354 (Video Phone) 

to make necessary arrangements. 

STATUS: Open. 

MATTERS TO BE CONSIDERED: Pursuant to 

the provisions of the ‘‘Government in 

the Sunshine Act’’ (5 U.S.C. 552b), 

notice is hereby given that the Federal 

Deposit Insurance Corporation’s Board 

of Directors will meet in open session to 

consider the following matters: 

Summary Agenda 

No substantive discussion of the 

following items is anticipated. These 

matters will be resolved with a single 

vote unless a member of the Board of 

Directors requests that an item be 

moved to the discussion agenda. 

Disposition of Minutes of a Board of 

Directors’ Meeting Previously 

Distributed. 

Memorandum and resolution re: Final 

Policy Statement Regarding Minority 

Depository Institutions. 

Memorandum and resolution re: 

Notice of Proposed Rulemaking on Real 

Estate Lending Standards. 

Status of report of actions taken 

pursuant to authority delegated by the 

Board of Directors. 

Discussion Agenda 

Memorandum and resolution re: 

Establishment of the FDIC Advisory 

Council on Innovation. 

Briefing: Restoration Plan Semiannual 

Update. 

CONTACT PERSON FOR MORE INFORMATION: 

Requests for further information 

concerning the meeting may be directed 

to Ms. Debra A. Decker, Deputy 

Executive Secretary of the Corporation, 

at 202–898–8748. 

Dated at Washington, DC, on June 10, 2021. 

Federal Deposit Insurance Corporation. 

James P. Sheesley, 

Assistant Executive Secretary. 

[FR Doc. 2021–12589 Filed 6–11–21; 11:15 am] 

BILLING CODE 6714–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2021–0060] 

Advisory Committee on Immunization 

Practices (ACIP) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. The meeting will be webcast live 

via the World Wide Web. Time will be 

available for public comment. 

DATES: The meeting will be held on June 

18, 2021, from 11:00 a.m. to 5:00 p.m., 

EDT (dates and times subject to change), 

see the ACIP website for updates: http:// 

www.cdc.gov/vaccines/acip/index.html. 

The public may submit written 

comments from June 15, 2021 through 

June 18, 2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0060 by any of the following methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

MS H24–8, Atlanta, Georgia 30329– 

4027, Attn: June 18, 2021 ACIP Meeting. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 


khammond on DSKJM1Z7X2PROD with NOTICES